Additional Proxy Soliciting Materials (definitive) (defa14a)
April 30 2019 - 8:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE
14A
Proxy Statement Pursuant to Section 14(a)
of the Securities
Exchange Act of 1934
Filed by the Registrant
x
Filed by a Party other than the Registrant
¨
Check the appropriate box:
¨
|
Preliminary Proxy Statement
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
¨
|
Definitive Proxy Statement
|
x
|
Definitive Additional Materials
|
¨
|
Soliciting Material Pursuant to §240.14a-12
|
AEVI GENOMIC
MEDICINE, INC.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x
|
No fee required.
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
¨
Fee paid previously
with preliminary materials.
¨
Check box
if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing.
1) Amount Previously Paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:
*** Exercise Your
Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on June
20, 2019 .Meeting Information AEVI GENOMIC MEDICINE, INC. Meeting Type: Annual Meeting For holders as of: April 26, 2019 Date:
June 20, 2019 Time: 10:00 AM EDT Location:Pepper Hamilton LLP New York Times Building 620 Eighth Avenue, 37th Floor New York,
NY 10018 You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot
use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are
available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy
(see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before
voting. AEVI GENOMIC MEDICINE, INC. 435 DEVON PARK DRIVE SUITE 715 WAYNE, PA 19087 E79435-P25074 See the reverse side of this
notice to obtain proxy materials and voting instructions.
Before You Vote
How to Access the Proxy Materials Proxy Materials Available to VIEW or RECEIVE:NOTICE AND PROXY STATEMENT ANNUAL REPORT How to
View Online: Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must
request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:1) BY INTERNET:
www.proxyvote.com 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com * If requesting materials by e-mail,
please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page)
in the subject line..XXXX XXXX XXXX XXXX.XXXX XXXX XXXX XXXX Requests, instructions and other inquiries sent to this e-mail address
will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 6, 2019 to facilitate
timely delivery. How To Vote E79436-P25074 Please Choose One of the Following Voting Methods Vote In Person: Many stockholder
meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity
holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you
will need to request a ballot to vote these shares. Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the
information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card..XXXX XXXX XXXX
XXXX
The Board of Directors
recommends you vote FOR the following:1. Election of Directors The Board of Directors recommends you vote FOR proposals 2 and
3 and “Every One Year” on proposal 4 .Nominees:1a. Sol J. Barer 2. To ratify the appointment of Ernst & Young
LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2019. 1b. Eugene A.
Bauer1c. Alastair Clemow 3. To approve, on a non-binding advisory basis, the compensation of the Company’s named executive
officers. 1d. Michael F. Cola 1e. Barbara G. Duncan 4. To indicate, on a non-binding advisory basis, the preferred frequency of
future executive compensation advisory votes. 1f. Matthew D. Bayley 1g. Joseph J. Grano NOTE: Such other business as may properly
come before the meeting or any adjournment thereof.E79437-P25074
E79438-P25074
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Apr 2023 to Apr 2024